NEW YORK ( TheStreet) -- CHANGE IN RATINGS
upgraded to buy at TheStreet Ratings.
First Majestic Silver
downgraded to hold at TheStreet Ratings.
(AVP - Get Report)
upgraded at B. Riley Caris from neutral to buy, B. Riley Caris said. $26 price target. Turnaround may not be smooth, but is occurring.
Avon upgraded at UBS to neutral from sell, UBS said. $21 price target. Despite strong quarter, recovery will not be linear.
Armstrong World Industries
upgraded at Citigroup to buy from neutral, Citigroup said. $67 price target. Improving nonresidential construction and low expectations.
Cliffs Natural Resources
(CLF - Get Report)
downgraded at Citigroup to neutral from buy, Citigroup said. $36 price target. Deeper issues than perceived.
Cliffs Natural downgraded at Deutsche from buy to hold, Deutsche Bank said. $38 price target. Unexpected share issuance will cause 19% to 21% dilution.
upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $48 price target. NBC Universal buyout is a positive and the company will return more cash to shareholders.
downgraded at Bernstein from outperform to market perform, Bernstein Research said. Valuation call, based on a $15 price target.
(FOSL - Get Report)
downgraded at FBR from market perform to underperform, FBR Capital Markets said. $95 price target. Earnings growth is decelerating.
(GRPN - Get Report)
upgraded at Sterne Agee from neutral to buy, Sterne Agee said. $9 price target. Contrarian call, based on the company's long-term prospects.
downgraded at UBS to neutral from buy, UBS said. $62 price target. Progress in restoring core US momentum remains slow.
upgraded at Wedbush to neutral from underperform, Wedbush said. $13 price target. LINZESS strong out of the gates.
upgraded at BofA to buy from neutral, Bank of America Merrill Lynch said. $41 price target. Strong momentum and HCR tailwinds.
downgraded at Citigroup to neutral from buy, Citigroup said. $48 price target. Valuation call.
upgraded at BofA to neutral from underperform, Bank of America Merrill Lynch said. $33 price target. M&A could yield further EPS upside.